Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Post
Print
Li Xing, PhD (she/her/hers)
CEO
LexBio Therapeutics
Poster(s):
(704) Discovery of highly potent and selective VAV1 molecular glue degraders for the treatment of inflammatory disorders
Saturday, April 18, 2026
2:30 PM - 3:30 PM
US ET